Skip to content

Clinical study on cell transplatation treatment for premature ovarian failure

Clinical study on cell transplatation treatment for premature ovarian failure

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONB-15007411
Enrollment
Unknown
Registered
2015-11-18
Start date
2015-11-02
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

premature ovarian failure

Interventions

Case series:self-adipose derived stem cell

Sponsors

Center for Reproductive Medicine,Shandong Provincial Hospital/ Reproductive Hospital Affiliated to Shandong University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. less than 40 years old; 2. less than 3 years from menopause; 3. not combined with male factor; 4. sporadic POF; 5. secondary amenorrhoea; 6. ovary size larger than 1*1cm by TVB.

Exclusion criteria

Exclusion criteria: 1. history of pelvic surgery; 2. combined with serious disease, such as heart diseases, diabetes, hypertension and hemorragic diseases that could not bear surgery.

Design outcomes

Primary

MeasureTime frame
antral follicle count;

Secondary

MeasureTime frame
FSH;LH;AMH;AMH;

Countries

China

Contacts

Public ContactJinlong Ma
Majinlong123@hotmail.com+86 18678856666

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026